Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA BSE: 524715

₹1748

-10 (0.57%)

Wed, 28 Oct 2026, 11:33 am

mtf coin illustrationMTF 5xInvest in Sun Pharmaceutical Industries Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)418194.25
PE Ratio34.67
Dividend0.92
Health TechnologyHealth Technology
Pharmaceuticals: MajorPharmaceuticals: Major
24.5K24.5K

Sun Pharmaceutical Industries Share Price Live Chart

1 Day

-10 (0.57%)

No Result Found

Summary

  • Market Cap (in Cr)

    422282.95

  • Net Profit (in Cr)

    11564.52

  • P/B

    5.05

  • Sector P/E

    36.16

  • P/E

    36.73

  • EV/EBITDA

    22.54

  • Debt/Equity (Industry)

    0.19

  • Interest Cover (Industry)

    13.14

  • ROCE (Industry)

    12.29

  • RONW (Industry)

    10.69

  • ROE

    14.85

  • ROCE

    18.72

  • Debt/Equity

    0.04

  • EPS (TTM)

    52.66

  • Dividend Yield

    0.91

  • Book Value

    348.31

  • Interest Cover

    45.61

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersSEPT 2026JUN 2026MAR 2026DEC 2025SEPT 2025
Promoters52.6854.4854.4854.4854.48
FII14.3614.5315.9416.1216.55
DII22.2722.1821.1120.8220.23
Public10.708.818.488.588.73
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

41.33

MACD

-27.18

50 DMA

1839.18

200 DMA

1808.43

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2162.432013.531915.071864.631766.171715.731566.83
Fibonacci2013.531956.651921.511864.631807.751772.611715.73
Camarilla1857.551843.901830.251864.631802.951789.301775.65

Pivots Level: Classic

R3

+297.80

2162.43

R2

+148.90

2013.53

R1

+50.43

1915.07

1864.63
1864.63
Pivot Point
LTP: 1757.50

S1

-98.47

1766.17

S2

-148.90

1715.73

S3

-297.80

1566.83

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1755.90

  • 20-EMA

    1774.37

  • 30-EMA

    1793.47

  • 50-EMA

    1819.99

  • 100-EMA

    1836.35

  • 200-EMA

    1815.81

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
11 Jun 2026agm
22 May 2026board-meetingsAccounts, Final Dividend
22 May 2026dividend₹5.00 Dividend /Share07 Jul 2026
31 Jan 2026dividend₹11.00 Dividend /Share05 Feb 2026
31 Jan 2026board-meetingsQuarterly Results, Interim Dividend
05 Jan 2026dividendInterim Dividend - Rs. - 1105 Feb 2026
05 Nov 2025board-meetingsQuarterly Results
07 Jun 2025dividendFinal Dividend - Rs. - 5.507 Jul 2025
22 May 2025agm
22 May 2025dividend₹5.50 Dividend /Share07 Jul 2025

Read More

Peer Comparison

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Zydus Lifesciences Ltd logo

Zydus Lifesciences Ltd

Laurus Labs Ltd logo

Laurus Labs Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Sun Pharmaceutical Industries Ltd About

Sun Pharmaceuticals Industries is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical ingredients.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1993

Headquarters

CEO

Dilip S Shanghvi

Employees

Contact

Website icon

Website

http://www.sunpharma.com

Email icon

Email

secretarial@sunpharma.com

Phone icon

Phone

91-265-6615500

Location icon

Location

Sun Pharma Advanced Res.Centre, Tandalja, Vadodara, Gujarat, 390020

Read More

Sun Pharmaceutical Industries Ltd Company History

YearHistory
2020
  • Launched FluGuard (Favipiravir) in India at Rs. 35 per tablet.
  • Introduced ABSORICA LD Capsules for severe recalcitrant nodular acne in the US.
2021
  • Launched website for Long Term Care Portfolio in the US.
  • Launched Sunkalp on National Doctors' Day.
  • Launched Chericof 12 in India for 12-hour cough relief.
2022
  • Entered license agreement with SPARC for commercialization of phenobarbital for injection in the US.
  • Expanded license and supply agreements with Cosmo for WINLEVI to include Japan.
  • Launched CEQUA, first dry eye treatment with nanomicellar technology, in Canada.
  • Obtained exclusive patent license from Lundbeck to introduce Vortioxetine in India.
  • Acquired Uractiv Portfolio from Fiterman Pharma in Romania.
2023
  • Entered licensing agreement with Zydus for co-marketing Desidustat in India.
  • US FDA accepted NDA filing for Deuruxolitinib.
  • Sun Pharma Canada launched PR WINLEVI (clascoterone cream 1% w/w) for acne.
  • Entered licensing agreement with Pharmazz Inc. for Tyvalzi (Sovateltide) in India.
  • Launched nationwide initiative Second Birth Date on National Doctor’s Day.
2024
  • Entered global exclusive commercialization, license, and supply agreement with Philogen for FIBROMUN.
  • Completed acquisition of all outstanding shares of Taro.
  • Included in S&P Global Sustainability Yearbook.
  • Launched STARIZO (Tedizolid Phosphate) in India for acute bacterial skin and skin structure infections.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828blockSell154424186824 Jun 2026
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794blockBuy154424186824 Jun 2026
GQG PARTNERS EMERGING MARKETS EQUITY CITblockBuy14464141763.918 Nov 2025
RELIANCE TRUST INSTITUTIONAL RETIREMENT TRUST SERIES TWELVEblockSell14464141763.918 Nov 2025
GOLDMAN SACHS (SINGAPORE) PTE - ODIblockSell1482331631.609 Oct 2025
GOLDMAN SACHS BANK EUROPE SE - ODIblockBuy1482331631.609 Oct 2025
THE MTBJ LTD.AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849blockBuy309391167214 Jul 2025
THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828blockSell309391167214 Jul 2025
THE JUPITER GLOBAL FUND-JUPITER INDIA SELECTblockBuy6562861556.9527 Feb 2024
JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITEDblockSell6562861556.9527 Feb 2024

Read More

Sun Pharmaceutical Industries Ltd News

Sun Pharma allots ₹7,816 crore NCDs

Sun Pharmaceutical Industries Limited completed the allotment of ₹7,816 crore in non-convertible debentures via private placement on October 26, 2026.

26 Oct 2026

companies

Sun Pharma's UNLOXCYT gets NCCN Category 2A nod

Sun Pharma announces UNLOXCYT received Category 2A Preferred Designation in NCCN Guidelines for locally advanced cutaneous squamous cell carcinoma, expanding its oncology footprint.

20 Oct 2026

companies

Sun Pharma board to consider NCD issue of ₹15,000 crore

Sun Pharmaceutical Industries' board will meet on October 12 to consider issuing NCDs up to ₹15,000 crore through private placement.

07 Oct 2026

companies

Sun Pharma funds $2.5M dermatology professorship at Mount Sinai

Sun Pharma established a $2.5 million endowed professorship in dermatology at Mount Sinai. Mark G. Lebwohl is the inaugural holder, supporting research and education.

06 Oct 2026

companies

Sun Pharma seeks shareholder approval for ESOP 2026 and Organon acquisition funding

Sun Pharma initiates postal ballot for ESOP 2026 and enhanced borrowing limits up to ₹700 billion to fund the proposed acquisition of Organon & Co.

01 Oct 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Sun Pharmaceutical Industries Ltd?

    As of 28/10/2026 at 5:03 PM, Sun Pharmaceutical Industries Ltd shares are trading at ₹1748.

  • 2.What is the market cap. of Sun Pharmaceutical Industries Ltd?

    As of 28/10/2026, the market capitalization of Sun Pharmaceutical Industries Ltd is ₹4,18,194.25 crore.

  • 3.When was Sun Pharmaceutical Industries Ltd founded?

    Sun Pharmaceutical Industries Ltd was founded in 1993.

  • 4.What are the P/E and P/B ratios of Sun Pharmaceutical Industries Ltd?

    As of 28/10/2026, Sun Pharmaceutical Industries Ltd has a P/E ratio of 34.67 and a P/B ratio of 5.05.

  • 5.How can I buy shares of Sun Pharmaceutical Industries Ltd?

    You can buy shares of Sun Pharmaceutical Industries Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Sun Pharmaceutical Industries Ltd?

    As of September,2026, promoters hold 52.68% in Sun Pharmaceutical Industries Ltd, while FIIs, DIIs and public shareholders hold 14.36%, 22.27% and 10.70%, respectively. The government holds 0.00%.

  • 7.Does Sun Pharmaceutical Industries Ltd pay dividends?

    Yes, Sun Pharmaceutical Industries Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹5.00 Dividend /Share per share.

  • 8.What is the dividend yield of Sun Pharmaceutical Industries Ltd?

    As of 28 October, 2026, the dividend yield of Sun Pharmaceutical Industries Ltd stands at 0.92%.

  • 9.What are the latest financial results of Sun Pharmaceutical Industries Ltd?

    For the financial year ended March 2025, Sun Pharmaceutical Industries Ltd reported revenue of ₹52,153.00 crore and a net profit of ₹10,929.00 crore.

  • 10.What is the Stock symbol of Sun Pharmaceutical Industries Ltd?

    SUNPHARMA is the stock symbol of Sun Pharmaceutical Industries Ltd.

  • 11.Who is the CEO of Sun Pharmaceutical Industries Ltd?

    The CEO of Sun Pharmaceutical Industries Ltd is Dilip S Shanghvi.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconsun pharmaceutical industries ltd
        • Overview
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo
        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links
        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map
        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds
        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers
        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800